Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) as a change in the internal blood coagulation pathway,
i.e., the activated partial thromboplastin time
Idiiatullina, Elina,
Al-Azab, Mahmoud,
Lin, Meng,
Hrovat-Schaale, Katja,
Liu, Ziyang,
Li, Xiaotian,
Guo, Caiqin,
Chen, Xixi,
Li, Yaoying,
Gao, Song,
Cui, Jun,
Zhou, Wenhao,
Liu, Li,
Zhang, Yuxia,
Masters, Seth L. (2024) , and autoinflammatory disease due to
type I IFN. Here, we show that a dominant negative mutation in the gene encoding
Abstract—
Type 2 diabetes is a complex and multifactorial metabolic disorder. The frequency of
type